The Apolipoprotein E ϵ4 Allele is not Associated With Cognitive Dysfunction in Cardiac Surgery

Annals of Thoracic Surgery

Volumn 86, Issue 3, 2008, Pages 841-847

  Silbert, Brendan S ^a,b   Evered, Lisbeth A ^a   Scott, David A ^a,b   Cowie, Tiffany F ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; DNA;

ADULT; AGED; ALLELE; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; BLOOD; GENETICS; POSTOPERATIVE COMPLICATION;

AGED; ALLELES; APOLIPOPROTEIN E4; COGNITION DISORDERS; CORONARY ARTERY BYPASS; FEMALE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POSTOPERATIVE COMPLICATIONS;

EID: 49549113870     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.085     Document Type: Article

References (33)

1. Newman M.F., Kirchner J.L., Phillips-Bute B., et al. Longitudinal assessment of neurocognitive function after coronary- artery bypass surgery. N Engl J Med 344 (2001) 395-402
2. Arrowsmith J.E., Grocott H.P., Reves J.G., and Newman M.F. Central nervous system complications of cardiac surgery. Br J Anaesth 84 (2000) 378-393
3. Hogue C., Palin C., and Arrowsmith J. Cardiopulmonary bypass management and neurologic outcomes; an evidence-based appraisal of current practices. Anesth Analg 103 (2006) 21-37
4. Martins I.J., Hone E., Foster J.K., et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11 (2006) 721-736
5. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med 9 (2003) 94-101
6. Henderson A.S., Easteal S., Jorm A.F., et al. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346 (1995) 1387-1390
7. Winblad B., Palmer K., Kivipelto M., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256 (2004) 240-246
8. DeCarli C., Miller B.L., Swan G.E., Reed T., Wolf P.A., and Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 58 (2001) 643-647
9. Traykov L., Rigaud A.S., Baudic S., Smagghe A., Boller F., and Forette F. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci 203-204 (2002) 177-181
10. Hogue Jr. C.W., Hershey T., Dixon D., et al. Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth Analg 102 (2006) 1602-1608
11. Grigore A.M., Mathew J., Grocott H.P., et al. Prospective randomized trial of normothermic versus hypothermic cardiopulmonary bypass on cognitive function after coronary artery bypass graft surgery. Anesthesiology 95 (2001) 1110-1119
12. Lewis M., Maruff P., Silbert B., Evered L., and Scott D. The sensitivity and specificity of three common statistical rules for the classification of post-operative cognitive dysfunction following coronary artery bypass graft surgery. Acta Anaesthiol Scand 50 (2006) 50-57
13. Tardiff B.E., Newman M.F., Saunders A.M., et al., The Neurologic Outcome Research Group of the Duke Heart Center. Preliminary report of a genetic basis for cognitive decline after cardiac operations. Ann Thorac Surg 64 (1997) 715-720
14. Steed L., Kong R., Stygall J., et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg 71 (2001) 823-826
15. Gaynor J.W., Gerdes M., Zackai E.H., et al. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. J Thorac Cardiovasc Surg 126 (2003) 1736-1745
16. Breslow J.L., Zannis V.I., SanGiacomo T.R., Third J.L., Tracy T., and Glueck C.J. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 23 (1982) 1224-1235
17. Corder E.H., Saunders A.M., Risch N.J., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7 (1994) 180-184
18. Silbert B.S., Scott D.A., Evered L.A., et al. A comparison of the effect of high- and low-dose fentanyl on the incidence of postoperative cognitive dysfunction after coronary artery bypass surgery in the elderly. Anesthesiology 104 (2006) 1137-1145
19. Collie A., Shafiq-Antonacci R., Maruff P., Tyler P., and Currie J. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust N Z J Psychiatry 33 (1999) 568-575
20. Rasmussen L.S., Larsen K., Houx P., Skovgaard L.T., Hanning C.D., and Moller J.T. The assessment of postoperative cognitive function. Acta Anaesthesiol Scand 45 (2001) 275-289
21. Silbert B.S., Scott D.A., Evered L.A., Lewis M.S., and Maruff P.T. Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery. Anesth Analg 104 (2007) 1023-1028
22. Silverstein J.H., Steinmetz J., Reichenberg A., Harvey P.D., and Rasmussen L.S. Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable?. Anesthesiology 106 (2007) 431-435
23. Nelson H. National Adult Reading Test (NART) for the assessment of premorbid intelligence in patients with dementia: test manual (1992), Psychological Corporation, Windsor, England
24. Murkin J.M., and Stump D.A. Conference on cardiac and vascular surgery: neurobehavioral assessment, physiological monitoring and cerebral protective strategies. Ann Thorac Surg 70 (2000) 1767-1769
25. Baird D.L., Murkin J.M., and Lee D.L. Neurologic findings in coronary artery bypass patients: perioperative or preexisting?. J Cardiothorac Vasc Anesth 11 (1997) 694-698
26. Manly J.J., Bell-McGinty S., Tang M.X., Schupf N., Stern Y., and Mayeux R. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 62 (2005) 1739-1746
27. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 256 (2004) 183-194
28. Hsiung G.Y., Sadovnick A.D., and Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171 (2004) 863-867
29. Lelis R.G., Krieger J.E., Pereira A.C., et al. Apolipoprotein E4 genotype increases the risk of postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery. J Cardiovasc Surg 47 (2006) 451-456
30. Abildstrom H., Christiansen M., Siersma V.D., and Rasmussen L.S. Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology 101 (2004) 855-861
31. Leung J.M., Sands L.P., Wang Y., et al. Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology 107 (2007) 406-411
32. Martins R.N., Clarnette R., Fisher C., et al. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport 6 (1995) 1513-1516
33. Wilson P.W., Schaefer E.J., Larson M.G., and Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16 (1996) 1250-1255